Capitalmind Flexi Cap Fund
The scheme seeks to generate long-term capital appreciation by investing predominantly in equity & equity related instruments across market capitalization i.e. large-cap, mid-cap and small-cap stocks.
Growthvine rating: 1/5 — ranked #53 of 56 in category.
Fund basics
| Category | Equity: Flexi Cap |
|---|
| NAV | ₹9.40 (as of 2026-10-23) |
|---|
| AUM | ₹476 Cr |
|---|
| Expense ratio | 2.08% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Anoop Vijaykumar |
|---|
| Exit load | 1% for redemption within 1 month |
|---|
Performance & risk
| Standard deviation | 0.00% |
|---|
| Max drawdown | −10.25% |
|---|
| Alpha | 0 |
|---|
| Beta | 0 |
|---|
Over 5 years, captured 80.6% of Nifty 500's upside and — of its downside.
Market cap allocation
| Large cap | 23.0% |
|---|
| Mid cap | 40.8% |
|---|
| Small cap | 36.3% |
|---|
Concentration
| Top 5 holdings | 22.1% |
|---|
| Top 10 holdings | 39.0% |
|---|
| Total holdings | 30 |
|---|
| Index overlap | 8.0% |
|---|
| Active share | 92.0% |
|---|
Top holdings
- Welspun Corp Limited — 6.3%
- Laurus Labs Limited — 4.4%
- Clearing Corporation of India Ltd — 4.2%
- Divis Laboratories Ltd. — 3.9%
- Bank of maharashtra — 3.8%
- Federal Bank Ltd. — 3.7%
- R R KABEL LIMITED — 3.5%
- Torrent Pharmaceuticals Ltd. — 3.5%
- Karur Vysya Bank Ltd. — 3.3%
- Karnataka Bank Ltd. — 3.3%
Top sectors
- Pharma & Biotech — 26.5%
- Banking & Financial — 23.7%
- Automobile — 15.3%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | −8.0% | Q3 | #32 of 50 |